Bazmpani MA, Papanastasiou CA, Kamperidis V et al (2022) Contemporary data on the status and medical management of acute heart failure. Curr Cardiol Rep 24:2009–2022. https://doi.org/10.1007/s11886-022-01822-1

Article  PubMed  PubMed Central  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2022) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 24(1):4–131. https://doi.org/10.1002/ejhf.2333

Article  PubMed  Google Scholar 

Elster SK, Braunwald E, Wood HF (1956) A study of C-reactive protein in the serum of patients with congestive heart failure. Am Heart J 51:533–541

Article  CAS  PubMed  Google Scholar 

Garofalo M, Corso R, Tomasoni D, Adamo M, Lombardi CM, Inciardi RM, Gussago C, Di Mario C, Metra M, Pagnesi M (2023) Inflammation in acute heart failure. Front Cardiovasc Med 17(10):1235178. https://doi.org/10.3389/fcvm.2023.1235178

Article  CAS  Google Scholar 

Kalogeropoulos AP, Tang WHW, Hsu A, Felker GM, Hernandez AF, Troughton RW et al (2014) High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. J Card Fail 20(5):319–326. https://doi.org/10.1016/j.cardfail.2014.02.002

Article  CAS  PubMed  Google Scholar 

Minami Y, Kajimoto K, Sato N, Hagiwara N, Takano T, Study Investigators ATTEND (2017) C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure. Eur Heart J Qual Care Clin Outcomes. 3(2):148–56. https://doi.org/10.1093/ehjqcco/qcw054

Article  PubMed  Google Scholar 

Michou E, Wussler D, Belkin M, Simmen C, Strebel I, Nowak A et al (2023) Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure. Eur J Heart Fail 25(2):174–184. https://doi.org/10.1002/ejhf.2767

Article  CAS  PubMed  Google Scholar 

Markousis-Mavrogenis G, Tromp J, Mentz RJ, O’Connor CM, Metra M, Ponikowski P et al (2021) The additive prognostic value of serial plasma interleukin-6 levels over changes in brain natriuretic peptide in patients with acute heart failure. J Card Fail 27(7):808–811. https://doi.org/10.1016/j.cardfail.2021.01.008

Article  PubMed  Google Scholar 

Cotter G, Davison B, Cohen-Solal A, Freund Y, Mebazaa A (2023) Targeting the ‘vulnerable’ period - first 3–6 months after an acute heart failure admission - the light gets brighter. Eur J Heart Fail 25(1):30–34. https://doi.org/10.1002/ejhf.2754

Article  PubMed  Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan — a web and mobile app for systematic reviews. Syst Rev 5:210. https://doi.org/10.1186/s13643-016-0384-4

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898

Article  PubMed  Google Scholar 

Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406

Article  PubMed  Google Scholar 

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 7(8):16. https://doi.org/10.1186/1745-6215-8-16

Article  Google Scholar 

Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48

Article  Google Scholar 

R Core Team (2021) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/. Accessed 14 Nov 2024

Gleser, L. J., & Olkin, I. (2009). Stochastically dependent effect sizes. In: Cooper H, Hedges LV, Valentine JC (Eds.) The handbook of research synthesis and meta-analysis, 2nd ed. Russell Sage Foundation, pp 357–376

Liu C, Liu K, COPE-ADHF Study Group (2014) Cardiac outcome prevention effectiveness of glucocorticoids in acute decompensated heart failure: COPE-ADHF study. J Cardiovasc Pharmacol 63(4):333–8. https://doi.org/10.1097/FJC.0000000000000048

Article  CAS  PubMed  Google Scholar 

Van Tassell BW, Canada J, Carbone S, Trankle C, Buckley L, OddiErdle C, Abouzaki NA, Dixon D, Kadariya D, Christopher S, Schatz A, Regan J, Viscusi M, Del Buono M, Melchior R, Mankad P, Lu J, Sculthorpe R, Biondi-Zoccai G, Lesnefsky E, Arena R, Abbate A (2017) Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial). Circ Heart Fail 10(11):e004373. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004373

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Tassell BW, Abouzaki NA, OddiErdle C, Carbone S, Trankle CR, Melchior RD, Turlington JS, Thurber CJ, Christopher S, Dixon DL, Fronk DT, Thomas CS, Rose SW, Buckley LF, Dinarello CA, Biondi-Zoccai G, Abbate A (2016) Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study. J Cardiovasc Pharmacol 67(6):544–551. https://doi.org/10.1097/FJC.0000000000000378

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cotter G, Davison BA, Freund Y, Voors AA, Edwards C, Novosadova M, Takagi K, Hayrapetyan H, Mshetsyan A, Mayranush D, Cohen-Solal A, Ter Maaten JM, Biegus J, Ponikowski P, Filippatos G, Chioncel O, Sadoune M, Pagnesi M, Simon T, Metra M, Mann DL, Mebazaa A (2024) Burst steroid therapy for acute heart failure: the CORTAHF randomized, open-label, pilot trial. Eur J Heart Fail. https://doi.org/10.1002/ejhf.3452

Pascual-Figal D, Núñez J, Pérez-Martínez MT, González-Juanatey JR, Taibo-Urquia M, Llàcer Iborra P, Delgado J, Villar S, Mirabet S, Aimo A, Riquelme-Pérez A, Anguita Sánchez M, Martínez-Sellés M, Noguera-Velasco JA, Ibáñez B, Bayés-Genís A; COLICA investigators (2024) Colchicine in acutely decompensated heart failure: the COLICA trial. Eur Heart J, ehae538. https://doi.org/10.1093/eurheartj/ehae538

Habibi D, Daneshpour MS, Asgarian S, Kohansal K, Hadaegh F, Mansourian M, Akbarzadeh M (2023) Effect of C-reactive protein on the risk of heart failure: a Mendelian randomization study. BMC Cardiovasc Disord 23(1):112

Article  PubMed  PubMed Central  Google Scholar 

Boulogne M, Sadoune M, Launay JM, Baudet M, Cohen-Solal A, Logeart D (2017) Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction. Int J Cardiol 226:53–59

Article  CAS  PubMed  Google Scholar 

Milo-Cotter O, Cotter-Davison B, Lombardi C, Sun H, Bettari L, Bugatti S, Rund M, Metra M, Kaluski E, Kobrin I, Frey A, Rainisio M, McMurray JJV, Teerlink JR, Cotter-Davison G (2011) Neurohormonal activation in acute heart failure: results from VERITAS. Cardiology 119:96–105

Article  CAS  PubMed  Google Scholar 

Milo O, Cotter G, Kaluski E, Brill A, Blatt A, Krakover R, Vered Z, Hershkoviz R (2003) Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol 92:222–226

Article  CAS  PubMed  Google Scholar 

Perez AL, Grodin JL, Chaikijurajai T, Wu Y, Hernandez AF, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, O’Connor C, Starling RC, Tang WHW (2021) Interleukin-6 and outcomes in acute heart failure: an ASCEND-HF substudy. J Card Fail 27:670–676

Article  PubMed  Google Scholar 

Felker GM, Cotter G (2006) Unraveling the pathophysiology of acute heart failure: an inflammatory proposal. Am Heart J 151(4):765–767. https://doi.org/10.1016/j.ahj.2005.07.004. (PMID: 16569529)

Article  PubMed  Google Scholar 

Petrie M, Borlaug BA, Buchholtz K, Ducharme A, Hvelplund A, Lam Su Ping C, Mendieta G, Hardt-Lindberg SO, Voors AA, Ridker PM. HERMES: effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation, J Cardiac Fail 30(1):126. https://doi.org/10.1016/j.cardfail.2023.10.024

Arvunescu AM, Ionescu RF, Dumitrescu SI, Zaharia O, Nanea TI (2024) Guideline-optimised treatment in heart failure-do higher doses reduce systemic inflammation more significantly? J Clin Med 13(11):3056. https://doi.org/10.3390/jcm13113056

Article  CAS  PubMed  PubMed Central  Google Scholar 

Markousis-Mavrogenis G, Baumhove L, Al-Mubarak AA, Aboumsallem JP, Bomer N, Voors AA, van der Meer P (2024) Immunomodulation and immunopharmacology in heart failure. Nat Rev Cardiol 21:119–149

Article  PubMed  Google Scholar 

Biegus J, Cotter G, Davison BA, Freund Y, Voors AA, Edwards C, Novosadova M, Takagi K, Hayrapetyan H, Mshetsyan A, Mayranush D, Cohen-Solal A, ter Maaten JM, Filippatos G, Chioncel O, Sadoune M, Pagnesi M, Simon T, Metra M, Mann DL, Mebazaa A, Ponikowski P (2024) The effects of burst steroid therapy on short-term decongestion in acute heart failure patients with pro-inflammatory activation: a post hoc analysis of the CORTAHF randomized, open-label, pilot trial. J Card Fail, S1071–9164(24)00376–2. https://doi.org/10.1016/j.cardfail.2024.09.002

Camilli M (2024) Is it possible to establish a threshold to define the inflammatory risk of acute heart failure patients? Letter regarding the article ‘Burst steroid therapy for acute heart failure: the CORTAHF randomized, open-label, pilot trial.’ Eur J Heart Fail 26(12):2619–2620. https://doi.org/10.1002/ejhf.3494

Article  PubMed  Google Scholar